You are here

Disease Prevention

Bivalent COVID-19 booster outperforms monovalent version --new study

A new Italian study finds that estimated relative vaccine effectiveness (rVE) was 49.3% for the bivalent (two-strain) booster and 26.9% for the monovalent (single-strain) booster, with protection lasting at least 4 months for the bivalent booster and waning fast for the monovalent version. The study appears in The Lancet Infectious Diseases.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

COVID-19 vaccine affected reduced deaths in seniors with dementia

For the first time, researchers have calculated excess deaths among US dementia patients during the pandemic, and they found a reduction in excess mortality among long-term care residents after COVID-19 vaccines were made available. The study was published today in JAMA Neurology.

ALSO SEE: Alzheimer’s among seniors is most common in the eastern and southeastern US states

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Disease Prevention
howdy folks
Page loaded in 0.727 seconds.